Literature DB >> 24287189

Sjögren's syndrome: an update on epidemiology and current insights on pathophysiology.

Tove R Reksten1, Malin V Jonsson.   

Abstract

Primary Sjögren's syndrome (pSS) is an autoimmune chronic inflammatory disorder affecting 0.2% to 3.0% of the population, with a 9:1 female to male ratio. Features are oral and ocular dryness, local and systemic autoantibody production, and progressive focal mononuclear cell infiltration in the affected salivary and lacrimal glands. Lymphoma is the most severe complication of pSS, occurring in 4% to 5% of patients. Genetic studies identified an association with HLA and susceptibility genes in cytokine genes and genes involved in B-cell differentiation. Genetic variations may help explain why disease manifestations differ among patients and supports the hypothesis of certain distinct disease phenotypes.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Autoimmune diseases; Epidemiology; Inflammatory disorder; Pathogenesis; Primary Sjögren's syndrome; Salivary glands; pSS

Mesh:

Substances:

Year:  2014        PMID: 24287189     DOI: 10.1016/j.coms.2013.09.002

Source DB:  PubMed          Journal:  Oral Maxillofac Surg Clin North Am        ISSN: 1042-3699            Impact factor:   2.802


  19 in total

1.  Swallowing Disorders in Sjögren's Syndrome: Prevalence, Risk Factors, and Effects on Quality of Life.

Authors:  Jenny L Pierce; Kristine Tanner; Ray M Merrill; Karla L Miller; Katherine A Kendall; Nelson Roy
Journal:  Dysphagia       Date:  2015-10-19       Impact factor: 3.438

2.  Interaction between innate immunity and Ro52-induced antibody causes Sjögren's syndrome-like disorder in mice.

Authors:  Barbara M Szczerba; Paulina Kaplonek; Nina Wolska; Anna Podsiadlowska; Paulina D Rybakowska; Paromita Dey; Astrid Rasmussen; Kiely Grundahl; Kimberly S Hefner; Donald U Stone; Stephen Young; David M Lewis; Lida Radfar; R Hal Scofield; Kathy L Sivils; Harini Bagavant; Umesh S Deshmukh
Journal:  Ann Rheum Dis       Date:  2015-02-05       Impact factor: 19.103

Review 3.  Oral manifestations of systemic disease.

Authors:  S R Porter; V Mercadante; S Fedele
Journal:  Br Dent J       Date:  2017-11-10       Impact factor: 1.626

4.  Risk of Sjögren's syndrome in Taiwanese female adults with irregular menstrual cycles: a population-based case-control study.

Authors:  Ming-Chi Lu; Min-Chih Hsieh; Malcolm Koo; Ning-Sheng Lai
Journal:  Rheumatol Int       Date:  2015-07-21       Impact factor: 2.631

5.  Blocking IAg7 class II major histocompatibility complex by drug-like small molecules alleviated Sjögren's syndrome in NOD mice.

Authors:  Shivai Gupta; Danmeng Li; David A Ostrov; Cuong Q Nguyen
Journal:  Life Sci       Date:  2021-11-27       Impact factor: 5.037

6.  Alteration in cellular turnover and progenitor cell population in lacrimal glands from thrombospondin 1-/- mice, a model of dry eye.

Authors:  Marie A Shatos; Robin R Hodges; Masahiro Morinaga; David E McNay; Rakibul Islam; Sumit Bhattacharya; Dayu Li; Bruce Turpie; Helen P Makarenkova; Sharmila Masli; Tor P Utheim; Darlene A Dartt
Journal:  Exp Eye Res       Date:  2016-09-30       Impact factor: 3.467

7.  Primary Biliary Cirrhosis and Primary Sjögren's Syndrome: Insights for the Stomatologist.

Authors:  Liliane Lins; Raymundo Paraná; Silvia Regina Almeida Reis; Antônio Fernando Pereira Falcão
Journal:  Case Rep Gastroenterol       Date:  2014-08-30

Review 8.  Multiple Roles for B-Lymphocytes in Sjogren's Syndrome.

Authors:  Julian Lawrence Ambrus; Lakshmanan Suresh; Ammon Peck
Journal:  J Clin Med       Date:  2016-10-08       Impact factor: 4.241

Review 9.  Extrahepatic Manifestations of Primary Biliary Cholangitis.

Authors:  Sara L Chalifoux; Peter G Konyn; Gina Choi; Sammy Saab
Journal:  Gut Liver       Date:  2017-11-15       Impact factor: 4.519

10.  Primary Sjögren's Syndrome Adversely Affects the Female Sexual Function Assessed by the Female Sexual Function Index: A Case-Control Study.

Authors:  Çağlar Yildiz; Savaş Karakuş; Özlem Bozoklu Akkar; Ali Şahin; Birkan Bozkurt; Ali Yanik
Journal:  Arch Rheumatol       Date:  2017-02-12       Impact factor: 1.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.